Green Planet Bio Engineering Co. Ltd. (ticker: GPLB) is an OTC-listed clinical research company. DredgeCap's structured extraction of GPLB's SEC filings surfaces 14 active risk signals, including 12 late-filing signals, and 2 auditor-change signals. GPLB reported no tagged revenue in revenue and -$36K for the period ending 2025-12-31, with operating cash flow of -$37K. Cash and equivalents stood at $0. Total assets of $0 are exceeded by total liabilities of $284K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
GPLB Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Green Planet Bio Engineering Co. Ltd. (GPLB) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.